Naluzotan

No registered brands found for this active ingredient.

No food notes on record for this active ingredient.

• OliceridineMAJOR

  The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Naluzotan is combined with Oliceridine.

  Expert view
• 1-benzylimidazoleMODERATE

  The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Naluzotan.

  Expert view
• 2,5-Dimethoxy-4-ethylamphetamineMODERATE

  The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Naluzotan.

  Expert view
• 4-Bromo-2,5-dimethoxyamphetamineMODERATE

  The risk or severity of CNS depression can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Naluzotan.

  Expert view
• 4-hydroxycoumarinMODERATE

  The risk or severity of adverse effects can be increased when Naluzotan is combined with 4-hydroxycoumarin.

  Expert view
• 4-MethoxyamphetamineMODERATE

  The risk or severity of CNS depression can be increased when 4-Methoxyamphetamine is combined with Naluzotan.

  Expert view
• 7-NitroindazoleMODERATE

  The risk or severity of CNS depression can be increased when 7-Nitroindazole is combined with Naluzotan.

  Expert view
• AcebutololMODERATE

  Naluzotan may decrease the antihypertensive activities of Acebutolol.

  Expert view
• AcenocoumarolMODERATE

  The risk or severity of adverse effects can be increased when Naluzotan is combined with Acenocoumarol.

  Expert view
• AcepromazineMODERATE

  The risk or severity of CNS depression can be increased when Acepromazine is combined with Naluzotan.

  Expert view